Oncology and Hematology
65-80 of 612
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
- MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
1.00 program creditA.J. Gelderblom, MD, PhD
- MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
1.00 program creditA.J. Gelderblom, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Charles E. Geyer Jr., MD, FACP
- Oncology and Hematology
Additional Safey Data From TROPION-Breast02 and Study Design of TROPION-Breast06
Komal Jhaveri, MD, FACP
Charles E. Geyer Jr., MD, FACP
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
Jacob Sands, MD
Aaron Lisberg, MD
Jacob Sands, MD
Julia Rotow, MD
Xiuning Le, MD, PhD
